Return to search

Persistence Capital taps Norman Steinberg as senior advisor

Canadian healthcare private equity firm Persistence Capital Partners (PCP) has appointed Norman M. Steinberg as a senior advisor. Steinberg is currently chair emeritus of Norton Rose Fulbright Canada. In the period 2005 to March 2017, he was co-chair and then chair of Norton Rose Fulbright and its predecessor, Ogilvy Renault. During his 40-year legal career, he has focused on M&A, corporate finance and corporate governance, and advised on key Canadian deals. Steinberg will advise PCP as the firm explores new healthcare opportunities. He will also provide strategic and operational advice to portfolio companies.

PRESS RELEASE

Persistence Capital Partners Appoints Norman M. Steinberg as Senior Advisor

MONTREAL, Sept. 25, 2017 /CNW Telbec/ – Persistence Capital Partners (“PCP”), Canada’s leading healthcare focused private equity fund, is pleased to announce the appointment of Norman M. Steinberg as a Senior Advisor to the firm.

Mr. Steinberg is Chair Emeritus of Norton Rose Fulbright Canada. Throughout his distinguished career, he has held multiple senior leadership positions, including as the former Global Chair of Norton Rose Fulbright, one of the largest law firms in the world with 4,000 lawyers located in 58 cities across the globe. His career has focused on advising some of the world’s largest companies, focusing on M&A, corporate finance, corporate governance and leading legal teams in some of Canada’s most significant transactions.

“Norm brings with him an extensive knowledge base and a deep network of relationships across Canada and internationally, cultivated over his nearly 40-year career as a trusted advisor to Canada’s largest corporations,” said Dr. Sheldon Elman, Founding Partner of PCP. “Norm’s experience will be invaluable as we continue to see expanding opportunities across Canada and internationally for our portfolio companies, and we are thrilled to welcome him to the team.”

“I’m delighted to be joining the impressive team at PCP,” added Norm Steinberg. “PCP’s specialized focus on investing in Canadian healthcare businesses and their extensive experience as entrepreneurs, operators and investors positions PCP well for continued success. I look forward to working closely with PCP to both explore investment opportunities and provide strategic and operational advice to existing portfolio companies.”

“The addition of Norm to our team further strengthens our position as the partner of choice for leading healthcare management teams, founders and entrepreneurs,” said Stuart M. Elman, Managing Partner of PCP. “His strategic and global perspective, network of relationships and years of experience will enhance our ability to build market-leading companies and deliver superior returns for our investors in both of our current funds and our upcoming Fund III.”

Mr. Steinberg is Vice Chair of the Montreal Symphony Orchestra; Vice Chair of the McGill University Health Centre Foundation; a Director of BFL Canada; was Co-Chair of the 2007 Centraide (United Way) Campaign of Greater Montreal; former Chair of the Mount Royal Club of Montreal and the Canadian Club of Montreal; Co-Chair on a recent capital campaign of the Montreal Museum of Fine Arts and the Canadian Co-Chair of the Australia-Canada Economic Leadership Forum.

About Persistence Capital Partners

Persistence Capital Partners is Canada’s leading private equity fund exclusively focused on high-growth opportunities in the healthcare field. With deep healthcare industry expertise, PCP aims to create significant long-term capital appreciation for its investors by identifying and developing attractive investment opportunities in the Canadian healthcare market. PCP has offices in Montreal, Quebec, and Toronto, Ontario.

www.persistencecapital.com

For further information: Stuart M. Elman, Managing Partner, Persistence Capital Partners, +1 514 499-2778, Stuart.Elman@persistencecapital.com

Photo courtesy of Norton Rose Fulbright